Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000891020-04-000222
Filing Date
2004-02-13
Accepted
2004-02-13 15:23:08
Documents
2
Group Members
DOUGLAS FAMILY TRUST

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G v96461a2sc13gza.htm SC 13G/A 41256
3 EXHIBIT 24 v96461a2exv24.htm EX-24 6741
  Complete submission text file 0000891020-04-000222.txt   50062
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 04598455
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4040 CIVIC CENTER DRIVE SAN RAFAEL CA 94903
Business Address 4040 CIVIC CENTER DRIVE SAN RAFAEL CA 94903
DOUGLAS KEVIN (Filed by) CIK: 0001132859 (see all company filings)